SCHEMBL3467347

SCHEMBL3467347

NN(CCC(=O)O)C(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 1/20 0.48
ADRA2C P18825 1/20 0.45
ALDH1A1 P00352 4/20 0.44
CYP2C19 P33261 2/20 0.44
GAA P10253 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
TDP1 Q9NUW8 3/20 0.43
KMT2A Q03164 2/20 0.43
MAPK1 P28482 2/20 0.43
HPGD P15428 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8658431 0.98 NR4A2 (0.47) NR4A2ADRA2CALDH1A1CYP2C19GAA
SCHEMBL19248951 0.86 HDAC3 (0.56) NR4A2ADRA2CHDAC3HDAC4HDAC1
SCHEMBL11218379 0.86 HDAC3 (0.56) NR4A2ADRA2CHDAC3HDAC4HDAC1
SCHEMBL11115293 0.86 HDAC1 (0.51) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL7401269 0.84 CYP1A2 (0.47) ALDH1A1CYP2C19GAATDP1KMT2A
SCHEMBL3657378 0.82 ADRA2C (0.46) ADRA2CALDH1A1CYP2C19HDAC3HDAC4
SCHEMBL28986867 0.81 ALDH1A1 (0.50) ADRA2CALDH1A1CYP2C19TDP1KMT2A
SCHEMBL18670066 0.80 ALDH1A1 (0.43) NR4A2ADRA2CALDH1A1CYP2C19TDP1
Succinic Acid SCHEMBL27852517 0.80 NR4A2 (0.57) NR4A2ADRA2CALDH1A1CYP2C19GAA
SCHEMBL13724448 0.79 ADRA2C (0.47) ADRA2CALDH1A1CYP2C19GAAHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010072734-A2 TARGETING PRODRUGS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 2010-07-01 WO disclosed
CN-101503377-A Preparation of balsalazide disodium SHANXIN ANTER BIOLOG PHARMACY (CN) 2009-08-12 CN disclosed
EP-0859607-B1 GUANIDINO PROTEASE INHIBITORS DIMENSIONAL PHARM INC (US) 2002-12-18 EP disclosed
EP-0859607-A4 GUANIDINO PROTEASE INHIBITORS DIMENSIONAL PHARM INC (US) 1999-05-06 EP disclosed
EP-0869944-A1 N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-10-14 EP disclosed
EP-0859607-A1 GUANIDINO PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1998-08-26 EP disclosed
US-5792769-A POTENT ANTICOAGULANT, ANTIINFLAMMATORY AGENT; TREATMENT/PROPHYLAXIS OF RESPIRATORY SYSTEM DISORDERS, VASCULAR SYSTEM DISORDERS, ANTITUMOR AGENTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1998-08-11 US disclosed
WO-1997011693-A1 GUANIDINO PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1997-04-03 WO disclosed